Pfizer Inc (PFE)
28.17
+0.36
(+1.29%)
USD |
NYSE |
May 06, 16:00
28.25
+0.08
(+0.28%)
After-Hours: 20:00
Pfizer Commercial Paper Liability (Quarterly)
Commercial Paper Liability (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Commercial Paper Liability (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -- |
September 30, 2023 | -- |
June 30, 2023 | -- |
March 31, 2023 | -- |
December 31, 2022 | -- |
September 30, 2022 | -- |
June 30, 2022 | -- |
March 31, 2022 | -- |
December 31, 2021 | -- |
September 30, 2021 | -- |
June 30, 2021 | -- |
March 31, 2021 | -- |
December 31, 2020 | -- |
September 30, 2020 | -- |
June 30, 2020 | -- |
Date | Value |
---|---|
March 31, 2020 | -- |
December 31, 2019 | -- |
September 30, 2019 | -- |
June 30, 2019 | -- |
March 31, 2019 | -- |
December 31, 2018 | -- |
September 30, 2018 | -- |
June 30, 2018 | -- |
March 31, 2018 | -- |
December 31, 2017 | -- |
September 30, 2017 | -- |
June 30, 2017 | -- |
March 31, 2017 | -- |
December 31, 2016 | -- |
Commercial Paper Liability (Quarterly) Range, Past 5 Years
Commercial Paper Liability (Quarterly) Benchmarks
Amgen Inc | -- |
Johnson & Johnson | -- |
Eli Lilly and Co | -- |
Viking Therapeutics Inc | -- |
Moderna Inc | -- |